(CC) Chemours - Ratings and Ratios
Refrigerants, Pigments, Coatings, Membranes, Polymers
Dividends
| Dividend Yield | 3.97% |
| Yield on Cost 5y | 2.37% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 85.4% |
| Payout Ratio | 50.4% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 55.0% |
| Value at Risk 5%th | 82.2% |
| Relative Tail Risk | -9.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -61.50 |
| CAGR/Max DD | -0.30 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.452 |
| Beta | 2.026 |
| Beta Downside | 1.775 |
| Drawdowns 3y | |
|---|---|
| Max DD | 73.60% |
| Mean DD | 37.20% |
| Median DD | 36.62% |
Description: CC Chemours November 13, 2025
Chemours Co (NYSE:CC) is a diversified performance-chemicals producer operating worldwide through three business units: Thermal & Specialized Solutions (refrigerants, propellants, foam-blowing agents under Freon/Opteon), Titanium Technologies (Ti-O₂ pigment sold as Ti-Pure for coatings, packaging and paper applications), and Advanced Performance Materials (specialty polymers and membranes under Teflon, Viton, Krytox, Nafion serving electronics, semiconductor, transportation, energy and medical markets). The company distributes its products via direct sales, resellers, agents and distributors, and has been a standalone public entity since its 2014 spin-off.
Key quantitative drivers include FY 2023 revenue of roughly $6.6 billion with an adjusted EBITDA margin near 15%, while the Thermal segment’s growth is tied to global HFC phase-down regulations that favor low-global-warming-potential refrigerants such as Opteon. Ti-O₂ demand remains correlated with construction and automotive activity, giving the Titanium Technologies segment a cyclic exposure to GDP-linked capex. The Advanced Performance Materials unit benefits from secular trends in semiconductor fabrication and electric-vehicle battery production, which have been expanding the addressable market for high-performance fluoropolymers.
For a deeper, data-rich assessment of Chemours’ valuation and risk profile, you may find the analyst tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-333.0m TTM) > 0 and > 6% of Revenue (6% = 352.3m TTM) |
| FCFTA -0.00 (>2.0%) and ΔFCFTA 8.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.60% (prev 22.35%; Δ 0.25pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 265.0m > Net Income -333.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.80b) to EBITDA (658.0m) ratio: 5.78 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.71 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (150.2m) change vs 12m ago 0.36% (target <= -2.0% for YES) |
| Gross Margin 17.40% (prev 19.44%; Δ -2.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 78.12% (prev 78.11%; Δ 0.02pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.25 (EBITDA TTM 658.0m / Interest Expense TTM 267.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.16
| (A) 0.18 = (Total Current Assets 3.21b - Total Current Liabilities 1.88b) / Total Assets 7.57b |
| (B) 0.17 = Retained Earnings (Balance) 1.31b / Total Assets 7.57b |
| (C) 0.04 = EBIT TTM 333.0m / Avg Total Assets 7.52b |
| (D) 0.14 = Book Value of Equity 1.03b / Total Liabilities 7.27b |
| Total Rating: 2.16 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 37.47
| 1. Piotroski 2.50pt |
| 2. FCF Yield -0.21% |
| 3. FCF Margin -0.20% |
| 4. Debt/Equity 14.82 |
| 5. Debt/Ebitda 5.78 |
| 6. ROIC - WACC (= 3.22)% |
| 7. RoE -77.53% |
| 8. Rev. Trend -50.71% |
| 9. EPS Trend -51.39% |
What is the price of CC shares?
Over the past week, the price has changed by +1.97%, over one month by +3.44%, over three months by -22.13% and over the past year by -30.69%.
Is CC a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.8 | 21.9% |
| Analysts Target Price | 15.8 | 21.9% |
| ValueRay Target Price | 11.8 | -9.1% |
CC Fundamental Data Overview December 05, 2025
P/E Forward = 6.5445
P/S = 0.3328
P/B = 6.5188
P/EG = 1.6685
Beta = 1.583
Revenue TTM = 5.87b USD
EBIT TTM = 333.0m USD
EBITDA TTM = 658.0m USD
Long Term Debt = 4.10b USD (from longTermDebt, last quarter)
Short Term Debt = 114.0m USD (from shortTermDebt, last quarter)
Debt = 4.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.80b USD (from netDebt column, last quarter)
Enterprise Value = 5.74b USD (1.94b + Debt 4.42b - CCE 613.0m)
Interest Coverage Ratio = 1.25 (Ebit TTM 333.0m / Interest Expense TTM 267.0m)
FCF Yield = -0.21% (FCF TTM -12.0m / Enterprise Value 5.74b)
FCF Margin = -0.20% (FCF TTM -12.0m / Revenue TTM 5.87b)
Net Margin = -5.67% (Net Income TTM -333.0m / Revenue TTM 5.87b)
Gross Margin = 17.40% ((Revenue TTM 5.87b - Cost of Revenue TTM 4.85b) / Revenue TTM)
Gross Margin QoQ = 15.72% (prev 17.21%)
Tobins Q-Ratio = 0.76 (Enterprise Value 5.74b / Total Assets 7.57b)
Interest Expense / Debt = 1.54% (Interest Expense 68.0m / Debt 4.42b)
Taxrate = -17.65% (negative due to tax credits) (-9.00m / 51.0m)
NOPAT = 391.8m (EBIT 333.0m * (1 - -17.65%)) [negative tax rate / tax credits]
Current Ratio = 1.71 (Total Current Assets 3.21b / Total Current Liabilities 1.88b)
Debt / Equity = 14.82 (Debt 4.42b / totalStockholderEquity, last quarter 298.0m)
Debt / EBITDA = 5.78 (Net Debt 3.80b / EBITDA 658.0m)
Debt / FCF = -316.8 (out of range, set to none) (Net Debt 3.80b / FCF TTM -12.0m)
Total Stockholder Equity = 429.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.40% (Net Income -333.0m / Total Assets 7.57b)
RoE = -77.53% (Net Income TTM -333.0m / Total Stockholder Equity 429.5m)
RoCE = 7.36% (EBIT 333.0m / Capital Employed (Equity 429.5m + L.T.Debt 4.10b))
RoIC = 8.60% (NOPAT 391.8m / Invested Capital 4.56b)
WACC = 5.38% (E(1.94b)/V(6.36b) * Re(13.48%) + D(4.42b)/V(6.36b) * Rd(1.54%) * (1-Tc(-0.18)))
Discount Rate = 13.48% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.55%
Fair Price DCF = unknown (Cash Flow -12.0m)
EPS Correlation: -51.39 | EPS CAGR: -31.13% | SUE: -0.34 | # QB: 0
Revenue Correlation: -50.71 | Revenue CAGR: -1.38% | SUE: -0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.13 | Chg30d=-0.202 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=1.79 | Chg30d=-0.259 | Revisions Net=-6 | Growth EPS=+83.4% | Growth Revenue=+4.1%
Additional Sources for CC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle